|
|
(HealthNewsDigest.com) – The University of South Australia’s Zlatko Kopecki has developed a product to help these kids, and which could potentially treat all people with inflammatory skin conditions.
“We have identified a harmful protein that impairs skin healing in these so-called ‘butterfly children’, and created a new product to address this,” explained Dr Kopecki.
“More broadly, the therapy we have developed may improve recovery from all kinds of wounds.”
Epidermolysis Bullosa occurs due to failure in scaffold-like structures that link skin cells to each other. With the normal protective barrier to the outside world now leaky, the child’s immune system is forced onto on a never-ending circuit of high alert and repair.
“If the children manage to survive the numerous infections they endure in early childhood, they die from skin cancers induced by this constant cycle,” said Dr Kopecki.
The new Epidermolysis Bullosa therapy dampens harmful inflammation in the skin by blocking the activity of a protein known as Flightless.
###
For advertising/promo rates, contact Mike McCurdy at 877-634-9180 or [email protected]